Relapsing multiple sclerosis
Not recruitingStudy on Fenebrutinib for Patients with Relapsing Multiple Sclerosis
- Disease:Relapsing multiple sclerosis
- Substances:–
Slovakia- Participants:18–64 years
- Sponsor:F. Hoffmann-La Roche AG
Rare diseases
Investigational molecules
Locations
Ruzinovska 6, Ruzinov, 826 06 Bratislava, Slovakia
University Hospital Bratislava in Bratislava, Slovakia specialises in clinical trials of conditions such as Relapsing multiple sclerosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of ophthalmology research, focusing on innovative treatments for macular edema secondary to retinal vein occlusion. This condition, characterized by swelling in the central part of the retina, can significantly impair vision.
Through cutting-edge research, the center is pioneering new approaches to improve visual outcomes and enhance the quality of life for patients with retinal conditions.
Specializing in orthopedics, the center is dedicated to advancing the treatment of rotator cuff tendinopathy. This condition, often resulting in significant shoulder pain and dysfunction, is a major focus of the center's research efforts.
The center's research aims to enhance therapeutic outcomes, reduce recovery times, and improve the overall functionality of patients suffering from severe shoulder conditions.
In the realm of infectious diseases, the center is leading research on treatments for complicated urinary tract infections (cUTI) and acute pyelonephritis (AP). These infections pose significant health challenges, particularly in hospitalized patients.
The center's work is crucial in developing more effective, patient-friendly treatment regimens that aim to improve clinical outcomes and reduce hospital stays.
More sites in BratislavaSlovakia
Clinical trials registered at this site – none is enrolling right now.
SlovakiaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.